First look: testing MRI dye safety in babies
NCT ID NCT05590884
Summary
This study aimed to understand how a new contrast agent (a special dye) for MRI scans is processed by the body in very young children. It involved 36 infants under 2 years old who needed an MRI. Researchers gave a single dose and took blood samples to measure how long the agent stayed in the body and to check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnatti Childrens Hospital
Cincinnati, Ohio, 45229, United States
-
Instytut "Pomnik - Centrum Zdrowia Dziecka"
Warsaw, Poland
-
Instytut Centrum Zdrowia Matki Polki
Lodz, Poland
-
Kliniczny Szpital Wojewodzki Nr 2 im. Sw. Jadwigi Krolowej
Rzeszów, Poland
-
Medical University of South Carolina
Charleston, South Carolina, 29425-8908, United States
-
Országos Idegtudományi Intézet
Budapest, Hungary
-
Semmelweis Egyetem
Budapest, 1094, Hungary
-
Szpital Uniwersytecki nr 1 im. dr Antoniego Jurasza
Bydgoszcz, Poland
-
University of Debrecen Clinical Center Pediatric Department
Debrecen, Hungary
-
Uniwersytecki Szpital Dzieciecy
Lublin, Poland
-
Uniwersyteckie Centrum Kliniczne Warszawskiego
Warsaw, 02-091, Poland
Conditions
Explore the condition pages connected to this study.